As the global economy recovers in 2021 and the supply of the industrial chain improves, the Live Attenuated Vaccines for Poultry market will undergo major changes. According to the latest research, the market size of the Live Attenuated Vaccines for Poultry industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Live Attenuated Vaccines for Poultry industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Live Attenuated Vaccines for Poultry market during the next few years. The global Live Attenuated Vaccines for Poultry market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The Live Attenuated Vaccines for Poultry market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Player list
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
HIPRA
Kemin Biologics
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC
Types list
Spray
Eye Drop
Oral
Others
Application list
Chicken
Cattle
Horse
Others